The DOI matches its Crossref record; 52 of the 52 references it cites were found in a registry or an index.
Acetaminophen (paracetamol) is a selective cyclooxygenase‐2 inhibitor in man
Abstract
For more than three decades, acetaminophen (INN, paracetamol) has been claimed to be devoid of significant inhibition of peripheral prostanoids. Meanwhile, attempts to explain its action by inhibition of a central cyclooxygenase (COX)‐3 have been rejected. The fact that acetaminophen acts functionally as a selective COX‐2 inhibitor led us to investigate the hypothesis of whether it works via preferential COX‐2 blockade. Ex vivo COX inhibition and pharma‐cokinetics of acetaminophen were assessed in 5 volunteers receiving single 1000 mg doses orally. Coagulation‐induced thromboxane B 2 and lipopolysaccharide‐induced prostaglandin E 2 were measured ex vivo and in vitro in human whole blood as indices of COX‐1 and COX‐2 activity. In vitro , acetaminophen elicited a 4.4‐fold selectivity toward COX‐2 inhibition (IC 50 = 113.7 μmol/L for COX‐1;IC 50 = 25.8 μmol/L for COX‐2). Following oral administration of the drug, maximal ex vivo inhibitions were 56% (COX‐1) and 83% (COX‐2). Acetaminophen plasma concentrations remained above the in vitro IC 50 for COX‐2 for at least 5 h postadministration. Ex vivo IC 50 values (COX‐1: 105.2 μmol/L; COX‐2: 26.3 μmol/L) of acetaminophen compared favorably with its in vitro IC 50 values. In contrast to previous concepts, acetaminophen inhibited COX‐2 by more than 80%, i.e. , to a degree comparable to nonste‐roidal antiinflammatory drugs (NSAIDs) and selective COX‐2 inhibitors. However, a >95% COX‐1 blockade relevant for suppression of platelet function was not achieved. Our data may explain acetaminophen's analgesic and antiinflammatory action as well as its superior overall gastrointestinal safety profile compared with NSAIDs. In view of its substantial COX‐2 inhibition, recently defined cardiovascular warnings for use of COX‐2 inhibitors should also be considered for acetaminophen.—Hinz, B., Cheremina, O., Brune, K. Acetaminophen (paracetamol) is a selective cyclooxygenase‐2 inhibitor in man. FASEB J. 22, 383–390 (2007)
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Hinz et al. (2007) demonstrated 4.4x more selectivity toward the inhibition of COX-2 (IC 50 = 25.8 µmol/L) over COX-1 (IC 50 = 113.7 µmol/ L) from in vitro assays using whole human blood [51].”
From Paracetamol (acetaminophen): A familiar drug with an unexplained mechanism of action (2021) · cites this paper as [51]
In the citing paper
“In this study, paracetamol demonstrated over 80% blockade of COX-2 activity comparable to NSAIDs and COX-2 selective inhibitors.”
From Paracetamol (acetaminophen): A familiar drug with an unexplained mechanism of action (2021) · cites this paper as [51]
In the citing paper
“It is not clear why there are significant discrepancies in relation to inhibition of COX-1 and COX-2 activities by paracetamol as reported by Hinz et al. [51] and Mitchell et al. [33].”
From Paracetamol (acetaminophen): A familiar drug with an unexplained mechanism of action (2021) · cites this paper as [51]
Citations
Cites
Chandrasekharan, N. V., Dai, H., Roos, K. L. T., Evanson, N. K., Tomsik, J., Elton, T. S., & Simmons, D. L. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.162468699 · Cited by 1,989 · cited 2×
“Attempts to explain the pharmacological action of acetaminophen as inhibition of a central COX isoform, derived from the same gene as COX-1 and referred to as COX-3 (8), have been meanwhile rejected for several reasons (9).”
BackgroundCyclooxygenase Inhibitors and the Antiplatelet Effects of Aspirin
Catella-Lawson, F., Reilly, M. P., Kapoor, S. C., Cucchiara, A. J., DeMarco, S., Tournier, B., Vyas, S. N., & FitzGerald, G. A. (2001) · New England Journal of Medicine · doi:10.1056/nejmoa003199 · Cited by 1,394
The antioxidants of human extracellular fluids
Halliwell, B., & Gutteridge, J. M. C. (1990) · Archives of Biochemistry and Biophysics · doi:10.1016/0003-9861(90)90510-6 · Cited by 1,341 · cited 1×
“Thus, the presence of various enzymatic and nonenzymatic antioxidant components in human plasma (33) may explain why acetaminophen elicited the most pronounced COX-2 inhibition in human whole blood as compared to the two other experimental systems.”
ResultSerhan, C. N., Clish, C. B., Brannon, J., Colgan, S. P., Chiang, N., & Gronert, K. (2000) · The Journal of Experimental Medicine · doi:10.1084/jem.192.8.1197 · Cited by 1,189 · cited 1×
“Apart from these factors, evidence for COX-2 inhibition by acetaminophen is also supported by previous findings showing that acetaminophen like indomethacin and aspirin confers the synthesis of 18R-hydroxyeicosapentaenoic acid (HEPE) and 15RHEPE through interaction with the COX-2 enzyme (34).”
ResultLangenbach, R., Morham, S. G., Tiano, H. F., Loftin, C. D., Ghanayem, B. I., Chulada, P. C., Mahler, J. F., Lee, C. A., Goulding, E. H., Kluckman, K. D., et al. (1995) · Cell · doi:10.1016/0092-8674(95)90126-4 · Cited by 1,123 · cited 1×
“A COXindependent mechanism for the gastrointestinal toxicity of NSAIDs is further supported by findings in COX-1 knockout mice, which still develop gastric erosions in response to oral administration of indomethacin (45).”
BackgroundPharmacological analysis of cyclooxygenase-1 in inflammation
Smith, C. J., Zhang, Y., Koboldt, C. M., Muhammad, J., Zweifel, B. S., Shaffer, A., Talley, J. J., Masferrer, J. L., Seibert, K., & Isakson, P. C. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.22.13313 · Cited by 807 · cited 2×
“A peripheral antiinflammatory action is further supported by findings showing acetaminophen as an inhibitor of nociception and edema in the rat carrageenan footpad model (27, 28), an inflammatory condition critically dependent on COX-2-derived PGs (29).”
BackgroundFLOWER, R. J., & VANE, J. R. (1972) · Nature · doi:10.1038/240410a0 · Cited by 779 · cited 2×
“Whereas the drug was first associated with a predominant suppression of PG synthesis in brain tissue ( 3 ), subsequent studies contradicted a cell-specific modulation (4 –7).”
BackgroundMethodMechanism of Action of Paracetamol
Graham, G. G., & Scott, K. F. (2005) · American Journal of Therapeutics · doi:10.1097/00045391-200501000-00008 · Cited by 648 · cited 4×
“Moreover, it turned out that acetaminophen elicits no measurable inhibition of PG formation in broken cell preparations but a profound suppression in intact cells (7).”
BackgroundInfluentialNonsteroidal anti-inflammatory drugs and gastroenteropathy: The second hundred years
Wallace, J. (1997) · Gastroenterology · doi:10.1053/gast.1997.v112.pm9041264 · Cited by 569
Cannon, C. P., Curtis, S. P., FitzGerald, G. A., Krum, H., Kaur, A., Bolognese, J. A., Reicin, A. S., Bombardier, C., Weinblatt, M. E., van der Heijde, D., et al. (2006) · The Lancet · doi:10.1016/s0140-6736(06)69666-9 · Cited by 522 · cited 1×
“PGE2 is the currently most plausible explanation for the cardiovascular hazard conferred by selective and nonselective COX-2 inhibitors (20, 30).”
Background
Research works printed but not linked: 1
- Mantzke U. S., 2002, Paracetamol in childhood. Current state of knowledge and indications for a rational approach to postoperative analgesia, Anaesthesist, 51, 735
Cited by
Mechanisms of drug combinations: interaction and network perspectives
Jia, J., Zhu, F., Ma, X., Cao, Z. W., Li, Y. X., & Chen, Y. Z. (2009) · Nature Reviews Drug Discovery · doi:10.1038/nrd2683 · Cited by 969
Rao, P., & Knaus, E. E. (2008) · Journal of Pharmacy & Pharmaceutical Sciences · doi:10.18433/j3t886 · Cited by 773
“However the final jury on this question is not out yet (78, 79).”
BackgroundGraham, G. G., Davies, M. J., Day, R. O., Mohamudally, A., & Scott, K. F. (2013) · Inflammopharmacology · doi:10.1007/s10787-013-0172-x · Cited by 671
Multiple Functions of Endocannabinoid Signaling in the Brain
Katona, I., & Freund, T. F. (2012) · Annual Review of Neuroscience · doi:10.1146/annurev-neuro-062111-150420 · Cited by 630
“…the highly potent analgesic effects of nonsteroidal anti-inflammatory drugs (NSAIDs) like paracetamol (acetaminophen), a selective COX-2 inhibitor (Hinz et al., 2008), or ibuprofen, a potent inhibitor of 2-AG oxidation by COX-2 (Prusakiewicz et al., 2009) require the activation of CB1 receptors…”
BackgroundNew insights into the use of currently available non-steroidal anti-inflammatory drugs
Brune, & Patrignani, P. (2015) · Journal of Pain Research · doi:10.2147/jpr.s75160 · Cited by 469
“38,39 42 Inhibition of prostanoid biosynthesis by NSAIDs is responsible for the therapeutic activities of these drugs; 11,32 however, this inhibitory activity also suppresses other effects of these prostanoids, resulting in the side effects associated with NSAID treatment.”
The Role of Cyclooxygenase-2 in Cell Proliferation and Cell Death in Human Malignancies
Sobolewski, C., Cerella, C., Dicato, M., Ghibelli, L., & Diederich, M. (2010) · International Journal of Cell Biology · doi:10.1155/2010/215158 · Cited by 354
“However, this hypothesis is debated because other findings argue that acetaminophen targets at the same time COX-2 [29].”
BackgroundSingle dose oral paracetamol (acetaminophen) for postoperative pain in adults
Toms, L., McQuay, H. J., Derry, S., & Moore, R. A. (2008) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd004602.pub2 · Cited by 311
Brausch, J. M., Connors, K. A., Brooks, B. W., & Rand, G. M. (2012) · Reviews of Environmental Contamination and Toxicology · doi:10.1007/978-1-4614-3137-4_1 · Cited by 258
Single dose oral analgesics for acute postoperative pain in adults - an overview of Cochrane reviews
Moore, R. A., Derry, S., Aldington, D., & Wiffen, P. J. (2015) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd008659.pub3 · Cited by 258
For the International NSAID Consensus Group, Scarpignato, C., Lanas, A., Blandizzi, C., Lems, W. F., Hermann, M., & Hunt, R. H. (2015) · BMC Medicine · doi:10.1186/s12916-015-0285-8 · Cited by 236
“The above findings are not surprising in the light of the recent discovery that paracetamol is indeed a selective cyclooxygenase (COX)-2 inhibitor in man [21].”
BackgroundSaragiotto, B. T., Machado, G. C., Ferreira, M. L., Pinheiro, M. B., Abdel Shaheed, C., & Maher, C. G. (2016) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd012230 · Cited by 215
Chronic, low concentration exposure to pharmaceuticals impacts multiple organ systems in zebrafish
Galus, M., Kirischian, N., Higgins, S., Purdy, J., Chow, J., Rangaranjan, S., Li, H., Metcalfe, C., & Wilson, J. Y. (2013) · Aquatic Toxicology · doi:10.1016/j.aquatox.2012.12.021 · Cited by 215
Paracetamol (acetaminophen): A familiar drug with an unexplained mechanism of action
Ayoub, S. S. (2021) · Temperature · doi:10.1080/23328940.2021.1886392 · Cited by 223
“7 μmol/ L) from in vitro assays using whole human blood [51].”
BackgroundMethodResultAcetaminophen/paracetamol: A history of errors, failures and false decisions
Brune, K., Renner, B., & Tiegs, G. (2015) · European Journal of Pain · doi:10.1002/ejp.621 · Cited by 213
“, 2002), we and others could show that paracetamol inhibits prostaglandin production by cyclooxygenase (COX) not only in the central nervous system but also in the peripheral tissues of human beings (Hinz et al., 2008).”
BackgroundSelf-citationSingle dose oral analgesics for acute postoperative pain in adults
Moore, R. A., Derry, S., McQuay, H. J., & Wiffen, P. J. (2011) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd008659.pub2 · Cited by 198
Chung, C.-W., Dean, A. W., Woolven, J. M., & Bamborough, P. (2012) · Journal of Medicinal Chemistry · doi:10.1021/jm201320w · Cited by 188
Drug-induced Hypertension: An Unappreciated Cause of Secondary Hypertension
Grossman, E., & Messerli, F. H. (2012) · The American Journal of Medicine · doi:10.1016/j.amjmed.2011.05.024 · Cited by 183
Behera, S. (2012) · Journal of Analytical & Bioanalytical Techniques · doi:10.4172/2155-9872.1000151 · Cited by 177
Targeting Nerve Growth Factor in Pain: What is the Therapeutic Potential?
Watson, J. J., Allen, S. J., & Dawbarn, D. (2008) · BioDrugs · doi:10.2165/0063030-200822060-00002 · Cited by 171
Acetaminophen Increases Blood Pressure in Patients With Coronary Artery Disease
Sudano, I., Flammer, A. J., Périat, D., Enseleit, F., Hermann, M., Wolfrum, M., Hirt, A., Kaiser, P., Hurlimann, D., Neidhart, M., et al. (2010) · Circulation · doi:10.1161/circulationaha.110.956490 · Cited by 175
Non-prescription (OTC) oral analgesics for acute pain - an overview of Cochrane reviews
Moore, R. A., Wiffen, P. J., Derry, S., Maguire, T., Roy, Y. M., & Tyrrell, L. (2015) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd010794.pub2 · Cited by 174
Single dose oral ibuprofen plus paracetamol (acetaminophen) for acute postoperative pain
Derry, C. J., Derry, S., & Moore, R. A. (2013) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd010210.pub2 · Cited by 173
Paracetamol versus placebo for knee and hip osteoarthritis
Leopoldino, A. O., Machado, G. C., Ferreira, P. H., Pinheiro, M. B., Day, R., McLachlan, A. J., Hunter, D. J., & Ferreira, M. L. (2019) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd013273 · Cited by 167
“Hinz 2008 Hinz B, Cheremina O, Brune K. Acetaminophen (paracetamol) is a selective cyclooxygenase-2 inhibitor in man.”
BackgroundSingle dose oral paracetamol (acetaminophen) with codeine for postoperative pain in adults
Toms, L., Derry, S., Moore, R. A., & McQuay, H. J. (2009) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd001547.pub2 · Cited by 166
North, T. E., Babu, I. R., Vedder, L. M., Lord, A. M., Wishnok, J. S., Tannenbaum, S. R., Zon, L. I., & Goessling, W. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1008209107 · Cited by 163
“Previous investigations of the relationship between PGE2 and APAP in liver injury are controversial; some studies suggest that APAP directly impacts cyclooxygenase-2 function (32), whereas the majority of research indicates that APAP does not work as a nonsteroidal antiinflammatory drug.”
BackgroundParacetamol (acetaminophen) with or without an antiemetic for acute migraine headaches in adults
Derry, S., & Moore, R. A. (2013) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd008040.pub3 · Cited by 158
Doherty, M., Hawkey, C., Goulder, M., Gibb, I., Hill, N., Aspley, S., & Reader, S. (2011) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2011.154047 · Cited by 160
Cardiovascular risk in rheumatoid arthritis
Nurmohamed, M. T. (2009) · Autoimmunity Reviews · doi:10.1016/j.autrev.2009.02.015 · Cited by 143
Eular Textbook on Rheumatic Diseases
Adwan, M. H. (2015) · Saudi Medical Journal · doi:10.15537/1658-3175.6383 · Cited by 145
Pharmaceuticals and personal care products: A critical review of the impacts on fish reproduction
Overturf, M. D., Anderson, J. C., Pandelides, Z., Beyger, L., & Holdway, D. A. (2015) · Critical Reviews in Toxicology · doi:10.3109/10408444.2015.1038499 · Cited by 149
“Acetaminophen has a mechanism of action very similar to that of NSAIDs, by inhibiting COX enzymes (Hinz et al. 2008); therefore, there is a potential for acetaminophen to interfere with reproduction.”
Oral nonsteroidal anti-inflammatory drugs (NSAIDs) for cancer pain in adults
Derry, S., Wiffen, P. J., Moore, A., McNicol, E. D., Bell, R. F., Carr, D. B., McIntyre, M., & Wee, B. (2017) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd012638.pub2 · Cited by 150
Toussaint, K., Yang, X. C., Zielinski, M. A., Reigle, K. L., Sacavage, S. D., Nagar, S., & Raffa, R. B. (2010) · Journal of Clinical Pharmacy and Therapeutics · doi:10.1111/j.1365-2710.2009.01143.x · Cited by 135
“Even if paracetamol inhibits peripheral COX-1, it is argued that it has too low a potency to produce pharmacological effects (86).”
BackgroundAn Update on Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) in Small Animals
Papich, M. G. (2008) · Veterinary Clinics of North America Small Animal Practice · doi:10.1016/j.cvsm.2008.09.002 · Cited by 154
Association of human papillomavirus infection and inflammation in cervical cancer
Hemmat, N., & Baghi, H. B. (2019) · Pathogens and Disease · doi:10.1093/femspd/ftz048 · Cited by 139
Nonsteroidal Anti-Inflammatory Drugs and the Heart
Patrono, C., & Baigent, C. (2014) · Circulation · doi:10.1161/circulationaha.113.004480 · Cited by 139
Integrating Cellular Metabolism into a Multiscale Whole-Body Model
Krauß, M., Schaller, S., Borchers, S., Findeisen, R., Lippert, J., & Kuepfer, L. (2012) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1002750 · Cited by 126
“Paracetamol is generally considered to be an inhibitor of prostaglandin synthesis and is widely used for reducing pain (analgesic) and fever (antipyretic) [62].”
BackgroundParacetamol and cyclooxygenase inhibition: is there a cause for concern?
Hinz, B., & Brune, K. (2011) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2011.200087 · Cited by 141
Self-citationParacetamol metabolism and related genetic differences
Zhao, L., & Pickering, G. P. (2010) · Drug Metabolism Reviews · doi:10.3109/03602532.2010.527984 · Cited by 138
“Recent findings in healthy volunteers receiving 1 g of paracetamol orally (Hinz et al., 2008) showed a substantial, selective inhibition of COX-2.”
BackgroundProstaglandins and bone metabolism
Choudhary, S., & Pilbeam, C. C. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-814841-9.00051-8 · Cited by 118
Overview of non-steroidal anti-inflammatory drugs (nsaids) in resource limited countries
Charles, F. (2018) · MOJ Toxicology · doi:10.15406/mojt.2018.04.00081 · Cited by 131
“Choosing an NSAID: Choosing an NSAID for its analgesic and antipyretic effect in indications like fever, common cold, dental pain, minor soft tissue injuries, musculo-skeletal pain, and nonspecific body aches is not difficult as in most circumstances the drug is to be used for a short duration only [17-19].”
BackgroundPerioperative Intravenous Acetaminophen and NSAIDs
Smith, H. S. (2011) · Pain Medicine · doi:10.1111/j.1526-4637.2011.01141.x · Cited by 116
Wilhelms, D., Kirilov, M., Mirrasekhian, E., Eskilsson, A., Kugelberg, U. Ö., Klar, C., Ridder, D. A., Herschman, H. R., Schwaninger, M., Blomqvist, A. G., et al. (2014) · Journal of Neuroscience · doi:10.1523/jneurosci.1838-14.2014 · Cited by 110
“Fever, which is a highly conserved trait of acute inflammatory activation (Kluger, 1991), is dependent on the prostaglandin cascade; inhibition of prostaglandin synthesis is the main mechanism of action for common antipyretic drugs, such as aspirin (Flower and Vane, 1972) and acetaminophen (Hinz et al., 2008; Engström…”
BackgroundCurrent etiological comprehension and therapeutic targets of acetaminophen-induced hepatotoxicity
Chowdhury, A., Jahan, N., Adelusi, T. I., & Wang, S. (2020) · Pharmacological Research · doi:10.1016/j.phrs.2020.105102 · Cited by 112
Genetic modulation of the pharmacological treatment of pain
Lötsch, J., Geißlinger, G., & Tegeder, I. (2009) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2009.06.010 · Cited by 114
“Metamizole (dipyrone) and acetaminophen also act by COX inhibition, although they are weaker and less specific (Muth-Selbach et al., 1999; Pierre et al., 2007; Hinz et al., 2008; Schildknecht et al., 2008).”
BackgroundDrug induced hypertension--An unappreciated cause of secondary hypertension.
Grossman, A., Messerli, F., & Grossman, E. (2015) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2015.06.027 · Cited by 241
“It can be mediated by COX-2 inhibition, by central COX-3 inhibition (Hinz et al., 2008) or by an indirect activation of cannabinoid receptors (Bertolini et al., 2006).”
BackgroundOral paracetamol (acetaminophen) for cancer pain
Wiffen, P. J., Derry, S., Moore, A., McNicol, E. D., Bell, R. F., Carr, D. B., McIntyre, M., & Wee, B. (2017) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd012637.pub2 · Cited by 118
Effect of antipyretic analgesics on immune responses to vaccination
Saleh, E., Moody, M. A., & Walter, E. B. (2016) · Human Vaccines & Immunotherapeutics · doi:10.1080/21645515.2016.1183077 · Cited by 100
Daniels, S. E., Goulder, M. A., Aspley, S., & Reader, S. (2011) · Pain · doi:10.1016/j.pain.2010.12.012 · Cited by 87
“In contrast, the mode of action of paracetamol, although not completely understood, appears to be related to the inhibition of a sub-class of cyclooxygenase enzyme isoforms in the central nervous system [7]; however, it has also been shown to cause COX-2 inhibition and may act as a weak NSAID when given at high doses…”
BackgroundSimpson, M. G., Drum, M., Nusstein, J., Reader, A., & Beck, M. (2011) · Journal of Endodontics · doi:10.1016/j.joen.2011.02.015 · Cited by 101
Henderson, A. J., & Shaheen, S. O. (2012) · Paediatric Respiratory Reviews · doi:10.1016/j.prrv.2012.04.004 · Cited by 86
Paracetamol (acetaminophen) for acute treatment of episodic tension-type headache in adults
Stephens, G., Derry, S., & Moore, A. (2016) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd011889.pub2 · Cited by 98
Klinger-Gratz, P. P., Ralvenius, W. T., Neumann, E., Kato, A., Nyilas, R., Lele, Z., Katona, I., & Zeilhofer, H. U. (2017) · Journal of Neuroscience · doi:10.1523/jneurosci.1945-17.2017 · Cited by 93
“An ex vivo study performed in human volunteers demonstrated inhibition of COX-1 and COX-2 following the oral administration of acetaminophen (Hinz et al., 2008), and AM 404 has also been shown to block COX-1 and COX-2 in lipopolysaccharidestimulated macrophages (Högestätt et al., 2005).”
BackgroundRayar, A.-M., Lagarde, N., Ferroud, C., Zagury, J., Montès, M., & Veitía, M. S. (2017) · Current Topics in Medicinal Chemistry · doi:10.2174/1568026617666170821124947 · Cited by 82
“Currently, the COX-2 binding potency remains unclear and controversial [48-51].”
BackgroundThe Biochemistry of Drug Metabolism – An Introduction: Part 5. Metabolism and Bioactivity
Testa, B., & Krämer, S. D. (2009) · Chemistry & Biodiversity · doi:10.1002/cbdv.200900022 · Cited by 91
“153) are caused by its capacity to inhibit prostaglandin synthesis, an inhibitory effect confirmed in intact cells [237] [238].”
BackgroundMoore, A., Derry, S., Aldington, D. J., & Wiffen, P. J. (2015) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd011407.pub2 · Cited by 83
Acetaminophen reduces lipopolysaccharide-induced fever by inhibiting cyclooxygenase-2
Engström Ruud, L., Wilhelms, D. B., Eskilsson, A., Vasilache, A. M., Elander, L., Engblom, D., & Blomqvist, A. (2013) · Neuropharmacology · doi:10.1016/j.neuropharm.2013.03.012 · Cited by 70
“Because acetaminophen was unable to reduce the LPS-induced PGE 2 increase in plasma [being contradictory to the observations by Hinz et al. (2008)], while reducing it in the brain, the authors deduced that the antipyretic effect of acetaminophen was due to inhibition of Cox-2 in the brain.”
Koelsch, M., Mallack, R., Graham, G. G., Kajer, T., Milligan, M. K., Nguyen, L. Q., Newsham, D. W., Keh, J. S., Kettle, A. J., Scott, K. F., et al. (2009) · Biochemical Pharmacology · doi:10.1016/j.bcp.2009.11.024 · Cited by 76
“These actions have been proposed to reflect inhibition of cyclooxygenase-2 via metabolism of acetaminophen by the peroxidase activity of this enzyme [18,19] and recent studies have shown that acetaminophen is a selective inhibitor of this enzyme in humans [20,21].”
Luz, J. G., Antonysamy, S., Kuklish, S. L., Condon, B., Lee, M. R., Allison, D., Yu, X., Chandrasekhar, S., Backer, R. T., Zhang, A., et al. (2015) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.5b00330 · Cited by 68
Gastrointestinal safety and tolerability of oral non-aspirin over-the-counter analgesics
Moore, N. D., & Scheiman, J. M. (2018) · Postgraduate Medicine · doi:10.1080/00325481.2018.1429793 · Cited by 67
“Indeed, the inhibition of prostaglandin production has been found in brain and spleen following treatment with acetaminophen and is consistent with COX-2 inhibition [35].”
BackgroundRosenblit, P. D. (2016) · Cardiovascular Diabetology · doi:10.1186/s12933-016-0412-7 · Cited by 75
“Analgesics Nonsteroidal anti-inflammatory drugs (NSAIDs), such as ibuprofen and naproxen, inhibit the activity of both cyclooxygenase-1 (COX-1) and -2 (COX-2) [131], whereas acetaminophen has been associated with selective COX-2 inhibition [132].”
BackgroundParacetamol (acetaminophen) for chronic non-cancer pain in children and adolescents
Cooper, T. E., Fisher, E., Anderson, B. J., Wilkinson, N. M., Williams, D. G., & Eccleston, C. (2017) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd012539.pub2 · Cited by 73
de Abajo, F. J., Gil, M., García-Poza, P., Bryant, V., Oliva, B., Timoner, J., & García‐Rodríguez, L. A. (2014) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.3617 · Cited by 75
Safety and efficacy of paracetamol and NSAIDs in osteoarthritis: which drug to recommend?
Richette, P., Latourte, A., & Frazier, A. (2015) · Expert Opinion on Drug Safety · doi:10.1517/14740338.2015.1056776 · Cited by 72
“Indeed, circulating plasma levels of acetaminophen after the administration of 1 g inhibited COX-2 activity to a degree similar to that with traditional NSAIDs and cyclooxygenase 2 (COX-2) inhibitors (coxibs) [35].”
MethodReist, L., Erlenwein, J., Meißner, W., Stammschulte, T., Stüber, F., & Stamer, U. M. (2018) · European Journal of Pain · doi:10.1002/ejp.1194 · Cited by 64
“…as harmless over decades, safety is now also questioned by studies reporting a paracetamol-induced COX-2-inhibition resulting in hypertension, cardio vascular events and bleeding disorders, specifically in the elderly (Chan et al., 2006; Hinz et al., 2008; Rahme et al., 2008; Sudano et al., 2010).”
BackgroundMoore, R. A., Derry, C. J., Derry, S., Straube, S., & McQuay, H. J. (2012) · European Journal of Pain · doi:10.1016/j.ejpain.2011.08.009 · Cited by 63
“For postoperative pain, combinations of paracetamol with NSAIDs have not been considered effective by some (Lange et al., 2007), while others show excellent efficacy (Moore et al., 2011b).”
BackgroundPPARγ activation prevents impairments in spatial memory and neurogenesis following transient illness
Ormerod, B. K., Hanft, S. J., Asokan, A., Haditsch, U., Lee, S. W., & Palmer, T. D. (2012) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2012.10.017 · Cited by 69
Barrière, D. A., Mallet, C., Blomgren, A., Simonsen, C., Daulhac, L., Libert, F., Chapuy, E., Etienne, M., Högestätt, E. D., Zygmunt, P. M., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0070690 · Cited by 62
“activation of spinal TRPA1 by electrophilic paracetamol metabolites [18] and inhibition of prostaglandin production [19].”
Paracetamol (Acetaminophen) and the Developing Brain
Bührer, C., Endesfelder, S., Scheuer, T., & Schmitz, T. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms222011156 · Cited by 95
Koh, W. U., Nguyen, K. P., & Jahr, J. S. (2015) · Korean Journal of Anesthesiology · doi:10.4097/kjae.2015.68.1.3 · Cited by 59
Paracetamol (acetaminophen) with or without codeine or dihydrocodeine for neuropathic pain in adults
Wiffen, P. J., Knaggs, R., Derry, S., Cole, P., Phillips, T., & Moore, A. (2016) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd012227.pub2 · Cited by 67
Effect of a cyclooxygenase-2 inhibitor on postexercise muscle protein synthesis in humans
Burd, N. A., Dickinson, J. M., LeMoine, J. K., Carroll, C. C., Sullivan, B. E., Haus, J. M., Jemioło, B., Trappe, S. W., Hughes, G. M., Sanders, C. E., et al. (2009) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00423.2009 · Cited by 65
“In addition, celecoxib does not provide any significant amount of COX-1 inhibition, whereas both ibuprofen and acetaminophen should block COX-1 at the doses used in each study (12, 21, 32, 55).”
Liu, M., Zhang, G., Song, M., Wang, J., Shen, C., Chen, Z., Huang, X., Gao, Y., Zhu, C., Lin, C., et al. (2020) · Antioxidants and Redox Signaling · doi:10.1089/ars.2019.7791 · Cited by 61
“Accumulating evidence points out that eicosanoids metabolism is dysregulated during APAP overdose, which is associated with the inflammation process (30, 51).”
Ubiquitous presence of paracetamol in human urine: sources and implications
Modick, H., Weiß, T., Dierkes, G., Brüning, T., & Koch, H. M. (2014) · Reproduction · doi:10.1530/rep-13-0527 · Cited by 58
Analgesic Use and Sex Steroid Hormone Concentrations in Postmenopausal Women
Gates, M. A., Tworoger, S. S., Eliassen, A. H., Missmer, S. A., & Hankinson, S. E. (2010) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-09-0975 · Cited by 56
“Acetaminophen has lower anti-inflammatory activity and is not considered an NSAID, although it seems to inhibit the COX-1 and COX-2 enzymes under certain conditions (19-21).”
Piroxicam-β-Cyclodextrin: A GI Safer Piroxicam
Scarpignato, C. (2013) · Current Medicinal Chemistry · doi:10.2174/09298673113209990115 · Cited by 65
Management of pain in end‐stage renal disease patients: Short review
Raina, R., Krishnappa, V., & Gupta, M. (2017) · Hemodialysis International · doi:10.1111/hdi.12622 · Cited by 56
How Can We Better Classify NSAID Hypersensitivity Reactions? – Validation from a Large Database
Caimmi, S. M. E., Caimmi, D. P., Bousquet, P., & Demoly, P. M. (2012) · International Archives of Allergy and Immunology · doi:10.1159/000337660 · Cited by 55
García-Poza, P., de Abajo, F. J., Gil, M., Chacón, A., Bryant, V., & García‐Rodríguez, L. A. (2015) · Journal of Thrombosis and Haemostasis · doi:10.1111/jth.12855 · Cited by 59
Clinical research in neonates and infants: Challenges and perspectives
Coppini, R., Simons, S. H. P., Mugelli, A., & Allegaert, K. (2016) · Pharmacological Research · doi:10.1016/j.phrs.2016.04.025 · Cited by 54
Drug Insight: cyclo-oxygenase-2 inhibitors—a critical appraisal
Hinz, B., Renner, B., & Brune, K. (2007) · Nature Clinical Practice Rheumatology · doi:10.1038/ncprheum0619 · Cited by 53
“Moreover, nonacidic antipyretic analgesics, such as acetaminophen and dipyrone, which have been claimed to exhibit no significant action on peripheral prostaglandin formation, elicit a substantial inhibition of COX2 in vivo”
BackgroundSelf-citationUzzaman, M., Shawon, J., & Siddique, Z. A. (2019) · SN Applied Sciences · doi:10.1007/s42452-019-1442-z · Cited by 53
Precaution, cyclooxygenase inhibition, and cardiovascular risk
Ritter, J. M., Harding, I., & Warren, J. B. (2009) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2009.07.007 · Cited by 52
Pain management in hemophilia: expert recommendations
Stromer, W., Pabinger, I., Ay, C., Crevenna, R., Donnerer, J., Feistritzer, C., Hemberger, S. H., Likar, R., Sevelda, F., Thom, K., et al. (2021) · Wiener klinische Wochenschrift · doi:10.1007/s00508-020-01798-4 · Cited by 53
Singer, E. A., Palapattu, G. S., & van Wijngaarden, E. (2008) · Cancer · doi:10.1002/cncr.23806 · Cited by 53
“Recently, acetaminophen has been suggested to selectively inhibit the COX-2 pathway in ex vivo and in vitro studies involving humans.(29) Several systematic reviews have examined the relation between NSAID/aspirin consumption and the risk of developing prostate cancer.”
BackgroundPharmacogenetics of analgesic drugs
Cregg, R., Russo, G. M., Gubbay, A., Branford, R., & Sato, H. (2013) · British Journal of Pain · doi:10.1177/2049463713507439 · Cited by 57
Twycross, R., Pace, V., Mihalyo, M., & Wilcock, A. (2013) · Journal of Pain and Symptom Management · doi:10.1016/j.jpainsymman.2013.08.001 · Cited by 61
Lauder, S. N., Taylor, P. R., Clark, S., Evans, R. L., Hindley, J. P., Smart, K., Leach, H., Kidd, E. J., Broadley, K. J., Jones, S. A., et al. (2011) · Thorax · doi:10.1136/thx.2010.150318 · Cited by 51
“A similar extent of PGE2 inhibition was observed with celecoxib and paracetamol, in line with reports of their comparable ability to inhibit PGE2 production in human blood.(8) Infection of mice with influenza virus typically results in occlusion of the lung airway spaces by inflammatory cell infiltration.”
BackgroundResultModick, H., Schütze, A., Pälmke, C., Weiß, T., Brüning, T., & Koch, H. M. (2013) · Journal of Chromatography B · doi:10.1016/j.jchromb.2013.02.023 · Cited by 48
Inflammation induced by human papillomavirus in cervical cancer and its implication in prevention
Parida, S., & Mandal, M. (2014) · European Journal of Cancer Prevention · doi:10.1097/cej.0000000000000023 · Cited by 53
Addo, K., Bulka, C. M., Dhingra, R., Junior, H. P. D. O. S., Smeester, L., O’Shea, T. M., & Fry, R. C. (2019) · Current Zoology · doi:10.1093/eep/dvz010 · Cited by 48
Anti-inflammatory and immunosuppressant drugs
Rang, H. P., Dale, M. M., Ritter, J., & Flower, R. J. (2007) · Elsevier eBooks · doi:10.1016/b978-0-443-06911-6.50019-0 · Cited by 48
Hughes, J. M., McKinnon, C. J., Taylor, K. M., Kardouni, J. R., Bulathsinhala, L., Guerriere, K. I., Popp, K. L., Bouxsein, M., Proctor, S. P., & Matheny, R. W. (2018) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.3616 · Cited by 50
“Moreover, acetaminophen has been shown to inhibit COX-2 in humanwhole blood and isolatedmonocytes, revealing anti-inflammatory activity similar to that found with NSAID exposure.((49))”
ResultChristophersen, O. A., & Haug, A. (2011) · Lipids in Health and Disease · doi:10.1186/1476-511x-10-16 · Cited by 52
“More recently, evidence has been presented that suggests acetaminophen may function as a selective COX-2 inhibitor in humans [176].”
BackgroundZhang, X., & Gong, Z. (2013) · PLoS ONE · doi:10.1371/journal.pone.0055474 · Cited by 46
“Acetaminophen is a popular and over-the-counter drug for treatment of headache and its main mechanism appears to be the inhibition of cycloxygenase (COX) [34].”
Straube, A. M., Aicher, B., Fiebich, B. L., & Haag, G. (2011) · BMC Neurology · doi:10.1186/1471-2377-11-43 · Cited by 50
“In some cell types, inhibition of PGE2 synthesis can be shown [106], but the mechanisms cannot be completely explained, especially since paracetamol does not inhibit the synthesis of prostaglandins in many peripheral immuno-competent and inflammatory cells, because in these cells, high peroxide levels block cyclooxyge…”
BackgroundWare, L. B., Files, D. C., Fowler, A., Aboodi, M. S., Aggarwal, N. R., Brower, R. G., Chang, S. Y., Douglas, I. S., Fields, S., Foulkes, A. S., et al. (2024) · JAMA · doi:10.1001/jama.2024.8772 · Cited by 45
Chandrashekharappa, S., Venugopala, K. N., Tratrat, C., Mahomoodally, M. F., Al‐Dhubiab, B. E., Haroun, M., Venugopala, R., Mohan, M. K., Kulkarni, R. S., Attimarad, M., et al. (2018) · New Journal of Chemistry · doi:10.1039/c7nj05010k · Cited by 45
Nonsteroidal Antiinflammatory Drugs, Acetaminophen, and Hypertension
Sudano, I., Flammer, A. J., Roas, S., Enseleit, F., Noll, G., & Ruschitzka, F. T. (2012) · Current Hypertension Reports · doi:10.1007/s11906-012-0274-7 · Cited by 47
Oral paracetamol (acetaminophen) for cancer pain
Wiffen, P. J., Derry, S., Moore, R. A., McNicol, E. D., Bell, R. F., Carr, D. B., McIntyre, M., & Wee, B. (2017) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd012637 · Cited by 45
Paracetamol (acetaminophen) with or without an antiemetic for acute migraine headaches in adults
Derry, S., Moore, R. A., & McQuay, H. J. (2010) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd008040.pub2 · Cited by 50
Metadata
- Authors
- Hinz, B., Cheremina, O., & Brune, K.
- Affiliations
- University of Rostock (DE)
- Friedrich-Alexander-Universität Erlangen-Nürnberg (DE)
- ORCID
- Hinz, Burkhard
- Venue
- The FASEB Journal
- Publisher
- Wiley
- Published
- 2007-09-20
- Volume
- 22
- Issue
- 2
- Pages
- 383-390
- ISSN
- 0892-6638 (ISSN-L)
- 1530-6860
- OpenAlex
- W2132889863
- Cited by
- 478
- References
- 51
- Citations by year
- 2026: 13 · 2025: 14 · 2024: 15 · 2023: 14 · 2022: 19 · 2021: 19 · 2020: 14 · 2019: 28 · 2018: 33 · 2017: 29 · 2016: 35 · 2015: 49 · 2014: 28 · 2013: 33 · 2012: 36
- FWCI
- 15.31
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- The FASEB Journal (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Pharmacology (medical) › Inflammatory mediators and NSAID effects
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmacology › Pharmacogenetics and Drug Metabolism
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Eicosanoids and Hypertension Pharmacology
- Keywords
- paracetamol, COX-2 inhibition, COX-1 inhibition, COX-2 inhibitors, thromboxane B2, prostaglandin E2, plasma pharmacokinetics, gastrointestinal safety, cardiovascular risk, analgesic mechanism, anti-inflammatory mechanism
- MeSH terms
- Acetaminophen, Cells, Cultured, Humans, Isoenzymes, Monocytes, Time Factors, Cyclooxygenase 1, Cyclooxygenase 2, Cyclooxygenase 2 Inhibitors
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.